Pillstats
Rx only · Suspension · Oral

Chlorothiazide

Brands: Diuril · Chlorothiazide

0 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US1 NDCs
0 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC03AA04
RxCUI (US)2396
US makers1 labelers
Packages1
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

n/a2.3K4.6K6.9K9.2K2025 Q12025 Q22025 Q32025 Q42026 Q1
35
Rx · 2025 Q4
2.9K
Units dispensed
4
Quarters · since 2025 Q1

Who makes it0 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Salix Pharmaceuticals, Inc.unknown1EXITED 2028

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Feb 10, 2026
    RESOLVEDShortage resolved: Chlorothiazide Oral Suspension (Salix Pharmaceuticals, a division of Bausch Health US, LLC)

    Chlorothiazide Oral Suspension — reported in shortage by Salix Pharmaceuticals, a division of Bausch Health US, LLC. Therapeutic category: Cardiovascular.

  • Feb 10, 2026
    SHORTAGEDrug shortage: Chlorothiazide Oral Suspension (Salix Pharmaceuticals, a division of Bausch Health US, LLC)

    Chlorothiazide Oral Suspension — reported in shortage by Salix Pharmaceuticals, a division of Bausch Health US, LLC. Therapeutic category: Cardiovascular.